 |
BioWorld-International-2008-12-17
Intercell Shares Rise on CHMP Positive Opinion for Ixiaro
Domain Raises €2.1M for Drug Discovery
No Abstract
BioWorld International Correspondent
PARIS - Domain Therapeutics SA, which was called Faust Pharmaceuticals SA until early December, has raised €2.1 million (US$2.8 million) to finance its drug discovery activities, which are focused on the identification of allosteric modulators of G Protein-Coupled Receptors (GPCRs).
Intercell Shares Rise on CHMP Positive Opinion for Ixiaro
Shares in Intercell AG rose by more than 8.5 percent Monday on news that the company's lead product, a vaccine against Japanese Encephalitis virus (JEV), received a positive opinion from the Committee on Human Medicinal Products, of the European Medicines Agency. (BioWorld International)